Harvard Bioscience Inc (HBIO): Operating Cash Flow
$6.73M
Year ended 2025-12-31
$651.0K
Trailing 12 months to 2026-06-30
+80.1%
3-year compound annual growth
-6.3%
5-year compound annual growth
+25.3%
10-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.73M | +367.3% | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | $1.44M | -89.7% | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | $14.03M | n/m | 2025-03-14, From 2023-01-01 |
| 2022-12-31 | $1.15M | -8.7% | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | $1.26M | -86.5% | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | $9.33M | +16.0% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $8.04M | +179.0% | 2021-03-17, From 2019-01-01 |
| 2018-12-31 | $2.88M | +172.8% | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | $1.06M | -80.4% | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | $5.38M | +663.5% | 2018-03-16, From 2016-01-01 |
| 2015-12-31 | $705.0K | -83.8% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $4.35M | +7.2% | 2017-03-17, From 2014-01-01 |
| 2013-12-31 | $4.06M | -49.6% | 2016-04-29, From 2013-01-01 |
| 2012-12-31 | $8.06M | +21.3% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $6.65M | -45.9% | 2014-03-14, From 2011-01-01 |
| 2010-12-31 | $12.29M | -25.5% | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $16.51M | n/a | 2012-03-15, From 2009-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $6.73M | +367.3% |
| 908 Devices Inc. (MASS) | 2025-12-31 | -$23.69M | n/m |
| Quanterix Corp (QTRX) | 2025-12-31 | -$77.24M | n/m |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | -$111.21M | n/m |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | -$4.69M | n/m |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | -$31.06M | n/m |
| EyePoint, Inc. (EYPT) | 2025-12-31 | -$240.11M | n/m |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | -$16.34M | n/m |
| Precipio, Inc. (PRPO) | 2025-12-31 | $685.0K | +56.0% |
Compare HBIO, MASS, QTRX, PACB side by side · Screen every company in Laboratory Analytical Instruments ↗